• LAST PRICE
    89.4000
  • TODAY'S CHANGE (%)
    Trending Down-1.8400 (-2.0167%)
  • Bid / Lots
    89.3300/ 2
  • Ask / Lots
    89.4100/ 2
  • Open / Previous Close
    90.9300 / 91.2400
  • Day Range
    Low 89.2900
    High 91.2300
  • 52 Week Range
    Low 76.0200
    High 103.5800
  • Volume
    366,507
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 91.24
TimeVolumeBMRN
09:32 ET1798790.9395
09:33 ET60091.07
09:35 ET20091.09
09:37 ET324490.77
09:39 ET164390.36
09:42 ET143490.26
09:44 ET1311090.19
09:46 ET140090.25
09:48 ET60090.21
09:50 ET22090.1553
09:51 ET586690.1
09:53 ET388090
09:55 ET1057690.2
09:57 ET73390.15
10:00 ET1457790.17
10:02 ET928790.06
10:04 ET50090.09
10:06 ET534089.98
10:08 ET810090.01
10:09 ET30090.01
10:11 ET173189.99
10:13 ET137389.873
10:15 ET959889.78
10:18 ET179989.705
10:20 ET120089.675
10:22 ET90089.57
10:24 ET319989.65
10:26 ET135589.52
10:27 ET162389.59
10:29 ET80089.575
10:31 ET155489.53
10:33 ET590489.7
10:36 ET129089.835
10:38 ET430089.85
10:40 ET50089.88
10:42 ET172990.03
10:44 ET143690.125
10:45 ET130090.27
10:47 ET100090.43
10:49 ET166490.4
10:51 ET90090.53
10:54 ET103690.51
10:56 ET81890.365
10:58 ET231490.12
11:00 ET676490.2585
11:02 ET110390.23
11:03 ET60090.23
11:05 ET200090.25
11:07 ET210190.25
11:09 ET130090.32
11:12 ET252790.16
11:14 ET120090.29
11:16 ET170090.37
11:18 ET104390.39
11:20 ET110090.46
11:21 ET80090.5
11:23 ET241290.35
11:25 ET215090.385
11:27 ET112690.415
11:30 ET318390.41
11:32 ET185890.36
11:34 ET124190.36
11:36 ET130690.25
11:38 ET157490.3
11:39 ET125690.26
11:41 ET449390.245
11:43 ET87190.23
11:45 ET272890.2
11:48 ET146290.215
11:50 ET290890.095
11:52 ET536890.11
11:54 ET110090.19
11:56 ET170090.25
11:57 ET180090.295
11:59 ET160090.3
12:01 ET316990.19
12:03 ET10090.18
12:06 ET110090.16
12:08 ET240090.075
12:10 ET100090.11
12:12 ET50090.14
12:14 ET200290.06
12:15 ET100090.05
12:17 ET245090
12:19 ET60089.92
12:21 ET83189.91
12:24 ET130089.89
12:26 ET139089.78
12:28 ET105789.795
12:30 ET440789.63
12:32 ET107789.6
12:33 ET70089.515
12:35 ET194989.5
12:37 ET142589.46
12:39 ET49789.47
12:42 ET40089.46
12:44 ET138789.51
12:46 ET60089.565
12:48 ET370589.61
12:50 ET191589.53
12:51 ET322789.34
12:53 ET30089.4
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBMRN
Biomarin Pharmaceutical Inc
17.2B
102.0x
---
United StatesBGNE
Beigene Ltd
16.8B
-17.1x
---
United StatesALNY
Alnylam Pharmaceuticals Inc
19.9B
-42.9x
---
United StatesNBIX
Neurocrine Biosciences Inc
13.4B
55.2x
+62.04%
United StatesUTHR
United Therapeutics Corp
10.7B
11.2x
+8.22%
United StatesEXAS
Exact Sciences Corp
10.4B
-50.3x
---
As of 2024-02-26

Company Information

BioMarin Pharmaceutical Inc. (BioMarin) is a biotechnology company that develops and commercializes therapies that address the root cause of genetic conditions. The Company's portfolio consists of seven commercial products and multiple clinical and preclinical product candidates for the treatment of various diseases. BioMarin's commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Kuvan (sapropterin dihydrochloride), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Roctavian (valoctocogene roxaparvovec) and Voxzogo (vosoritide). The Roctavian is an adeno associated virus (AAV5) vector drug development candidate designed to restore factor VIII plasma concentrations in patients with severe hemophilia A. The Company’s clinical development programs include BMN 331, an AAV5 mediated gene therapy for people living with Hereditary Angioedema (HAE) and BMN 255 is a small-molecule therapy that is designed to treat hyperoxaluria in chronic liver disease.

Contact Information

Headquarters
105 Digital DrNOVATO, CA, United States 94949-8703
Phone
415-506-6700
Fax
415-382-7889

Executives

Non-Executive Independent Chairman of the Board
Richard Meier
President, Chief Executive Officer, Director
Alexander Hardy
Chief Financial Officer, Executive Vice President - Finance
Brian Mueller
President - Worldwide Research and Development
Henry Fuchs
Executive Vice President - Global Manufacturing and Technical Operations, Chief Technical Officer
C. Greg Guyer

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$17.2B
Revenue (TTM)
$2.4B
Shares Outstanding
188.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.32
EPS
$0.88
Book Value
$26.25
P/E Ratio
102.0x
Price/Sales (TTM)
7.1
Price/Cash Flow (TTM)
63.2x
Operating Margin
6.54%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.